Prospeo
Hero Section BackgroundHero Section Background
Latigo Biotherapeutics

Latigo Biotherapeutics Revenue

Biotechnology ResearchFlag of USCasa Conejo, California, United States21-50 Employees

$

Latigo Biotherapeutics revenue & valuation

Annual revenue$3,935,530
Revenue per employee$86,000
Estimated valuation?$12,600,000
Total funding$300,000,000

Key Contacts at Latigo Biotherapeutics

Flag of US

Kevin Martin

Senior Director Of Drug Substance Development

Flag of US

Patrick Yang

Director Of Analytical Development And Quality Control

Flag of US

Nayan Solanki

Associate Director

Flag of US

Mallory Loflin

Senior Director, Clinical Development

Flag of US

Anne Arriaga

Sr. Director, Clinical Operations Late Phase

Flag of US

Jennifer Campbell

Business Operations Associate Director

Flag of US

Yibin Zeng

Director, Medicinal Chemistry

Company overview

HeadquartersCasa Conejo, California, United States
Website
NAICS541714
Employees21-50
Socials

Latigo Biotherapeutics Email Formats

Latigo Biotherapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@latigobio.com), used 67.5% of the time.

FormatExamplePercentage
{first initial}{last name}
jdoe@latigobio.com
67.5%
{first name}{last name}
johndoe@latigobio.com
32.5%

About Latigo Biotherapeutics

Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Senior
Director

Employees by Department

Latigo Biotherapeutics has 17 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Latigo Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2020-09-2115$15,000,000
2024-03-144$135,000,000
2025-04-175$150,000,000

Funding Insights

$300,000,000

Total funding amount

$150,000,000

Most recent funding amount

3

Number of funding rounds

Latigo Biotherapeutics Tech Stack

Discover the technologies and tools that power Latigo Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.

Site Kit

Site Kit

Analytics

Animate.css

Animate.css

UI frameworks

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

jQuery

jQuery

JavaScript libraries

PHP

PHP

Programming languages

WordPress

WordPress

Blogs

Google Analytics

Google Analytics

Analytics

HashThemes Total

HashThemes Total

WordPress themes

GoDaddy

GoDaddy

Hosting

Nginx

Nginx

Reverse proxies

Slider Revolution

Slider Revolution

Photo galleries

Frequently asked questions

Latigo Biotherapeutics is located in Casa Conejo, California, US.
Latigo Biotherapeutics generates an estimated annual revenue of $3,935,530. This revenue figure reflects the company's market position and business performance in its industry.
Latigo Biotherapeutics has an estimated valuation of $12,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Latigo Biotherapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Latigo Biotherapeutics has raised a total of $300,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles